DKN-01 Inhibition in Advanced Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)
- Status
- COMPLETED
- Phase
- PHASE2
CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE2
QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis
- Status
- UNKNOWN
- Phase
- PHASE4
HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE3
Sorafenib and Nivolumab in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis
- Status
- UNKNOWN
- Phase
- PHASE4
Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Efficacy and Safety of Sorafenib as Adjuvant and Latter Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Paediatric Hepatic International Tumour Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3